about
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk fo...
Read More
18.51
0.04
(0.22%)
2.0M
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Adma Biologics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..